CLChien-Te Lee

Chien-Te Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Chien-Te Lee has a total of 92 co-authors. Here are the top co-authors by number of shared publications:

  • Chung-Yao Hsu

    Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan

    4 shared publications
  • Wen-Chin Lee

    Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, Taiwan

    4 shared publications
  • Chih-Hsiung Lee

    Division of General Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan

    3 shared publications
  • Feng-Rong Chuang

    Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, 123 Ta Pei Road, Kaohsiung city, Niao Sung District, 833, Taiwan

    3 shared publications
  • Jin-Bor Chen

    Division of Nephrology, Department of Internal Medicine, Chang-Gung Memorial Hospital, Kaohsiung Medical Center

    3 shared publications
  • Jin-Bor Chen

    Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan

    3 shared publications

Latest Publications

  • Open Access

    Transcriptome Analysis in Rat Kidneys: Importance of Genes Involved in Programmed Hypertension

    by You-Lin Tain, Li-Tung Huang, Julie Y. H. Chan, Chien-Te Lee

    Suboptimal conditions in pregnancy can elicit long-term effects on the health of offspring. The most common outcome is programmed hypertension. We examined whether there are common genes and pathways in the kidney are responsible for generating programmed hypertension among three different models using next generation RNA sequencing (RNA-Seq) technology. Pregnant Sprague-Dawley rats received dexamethasone (DEX, 0.1 mg/kg) from gestational day 16 to 22, 60% high-fructose (HF) diet, or NG-nitro-l-arginine-methyester (l-NAME, 60 mg/kg/day) to conduct DEX, HF, or l-NAME model respectively. All three models elicited programmed hypertension in adult male offspring. We observed five shared genes (Bcl6, Dmrtc1c, Egr1, Inmt, and Olr1668) among three different models. The identified differential genes (DEGs) that are related to regulation of blood pressure included Aqp2, Ptgs1, Eph2x, Hba-a2, Apln, Guca2b, Hmox1, and Npy. RNA-Seq identified genes in arachidonic acid metabolism are potentially gatekeeper genes contributing to programmed hypertension. In addition, HF and DEX increased expression and activity of soluble epoxide hydrolase (Ephx2 gene encoding protein). Conclusively, the DEGs in arachidonic acid metabolism are potentially gatekeeper genes in programmed hypertension. The roles of DEGs identified by the RNA-Seq in this study deserve further clarification, to develop the potential interventions in the prevention of programmed hypertension.


  • Open Access

    Long-Term Effects of Maternal Citrulline Supplementation on Renal Transcriptome Prevention of Nitric Oxide Depletion-Related Programmed Hypertension: The Impact of Gene-Nutrient Interactions

    by You-Lin Tain, Chien-Te Lee, Li-Tung Huang

    Maternal malnutrition can elicit gene expression leading to fetal programming. l-citrulline (CIT) can be converted to l-arginine to generate nitric oxide (NO). We examined whether maternal CIT supplementation can prevent NG-nitro-l-arginine-methyl ester (l-NAME, NO synthase inhibitor)-induced programmed hypertension and examined their effects on the renal transcriptome in male offspring using next generation RNA sequencing (RNA-Seq) technology. Pregnant Sprague-Dawley rats received l-NAME administration at 60mg/kg/day subcutaneously via osmotic minipump during pregnancy alone or with additional 0.25% l-citrulline solution in drinking water during the whole period of pregnancy and lactation. Male offspring were assigned to three groups: control, l-NAME, and l-NAME + CIT. l-NAME exposure induced hypertension in the 12-week-old offspring, which CIT therapy prevented. Identified differentially expressed genes in l-NAME and CIT-treated offspring kidneys, including Guca2b, Hmox1, Hba2, Hba-a2, Dusp1, and Serpine1 are related to regulation of blood pressure (BP) and oxidative stress. In conclusion, our data suggests that the beneficial effects of CIT supplementation are attributed to alterations in expression levels of genes related to BP control and oxidative stress. Our results suggest that early nutritional intervention by CIT has long-term impact on the renal transcriptome to prevent NO depletion-related programmed hypertension. However, our RNA-Seq results might be a secondary phenomenon. The implications of epigenetic regulation at an early stage of programming deserve further clarification.


  • Open Access

    Renal MALT lymphoma associated with Waldenström macroglobulinemia

    by Po-Jui Chi, Sung-Nan Pei, Tung-Liang Huang, Shun-Chen Huang, Hwee Yeong Ng, Chien-Te Lee


  • Interleukin 10 and residual kidney function are associated with risk of vascular calcification in patients undergoing peritoneal dialysis

    by C.-T. Lee, Y.-C. Tsai, C.-Y. Su, H.-Y. Ng, C.-Y. Hsu, S.-F. Ko, T.-C. Chen, C.-C. Kuo, C.-C. Yang, T.T.-Y. Chiou, et al.

    Vascular calcification is a common complication among dialysis patients and its pathogenesis involves a variety of factors. The roles of pro-inflammatory cytokines and residual kidney function (RKF) in peritoneal dialysis (PD) patients with vascular calcification have not been investigated. 157 stable PD patients were enrolled. All patients had plain X-ray film examination including chest (posterior-anterior view, CXR) and pelvis. Vascular calcification was interpreted as calcified deposit over aortic arch and linear calcification of pelvic arteries. Relevant biochemical data, pro-inflammatory markers, and PD-related factors were measured and collected. Vascular calcification prevalence in CXRs was higher than that in pelvis films (38.2% vs. 22.3%, p < 0.05). Patients with vascular calcification in CXR had higher incidence of calcification in pelvis films (p < 0.05). Only a minor portion (14.6%) had two calcification sites. Regression analysis revealed that age, PD duration, body mass index, and RKF were independent factors associated with vascular calcification in CXR. Age, diabetes, IL-10 and RKF were factors associated in pelvis films. Factors independently related to vascular calcification in both films were age, duration, diabetes, IL-10, and RKF. Besides traditional risk factors, IL-10 and RKF were important factors associated with vascular calcification in PD patients.


  • Urinary UMOD Excretion and Chronic Kidney Disease in Gout Patients: Cross-Sectional Case–Control Study

    by Chien-Hsing Wu, Chien-Te Lee, Chih-Hsiung Lee, Tien-Tsai Cheng, Hsueh-Wen Chang, Eton Lin, Feng-Rong Chuang, Hui-Ping Yang, Ying-Chou Chen, Chung-Jen Chen

    Patients with gout often have concurrent chronic kidney disease (CKD); the relationship between the two conditions is still unclear. Previous studies have identified an association between low level of urinary uromodulin (UMOD) and CKD within the setting of diabetes and lupus. The aim of this study was to examine the association between urinary UMOD excretion and CKD in patients with gout. A total of 53 Taiwanese gout patients with stable disease activity were enrolled. Patients were divided into a CKD group (n = 25) and a non-CKD group (n = 28). Using Pearson correlation analysis, urinary UMOD excretion was positively correlated with estimated glomerular filtration rate (Ha: ρ > 0, p = 0.004). Using multivariate analysis, patients with CKD and gout were associated with lower urinary UMOD excretion than those who have gout alone [odds ratio (95% CI): 0.826 (0.694–0.985), p < 0.001]. Patients with CKD and gout were also more likely to be older (p < 0.001) and have higher uric acid levels (p < 0.001). This study implicates that UMOD might play a role in the relationship between gout and CKD. Further studies with animal models of gout and CKD would be recommended.


  • Comparison of clinical characteristics between automated peritoneal dialysis and continuous ambulatory peritoneal dialysis: a 2-year single-center observational study

    by Yu-Jen Su, Chien-Te Lee, Feng-Rong Chuang, Chih-Hsiung Lee, Yi-Chun Wang, Ben-Chung Cheng, Kuo-Tai Hsu, Jin-Bor Chen

    To date, there is convincing evidence for the preservation of residual renal function (RRF) in peritoneal dialysis (PD) patients; however, substantially variable data exist on the incidence rate of infectious complications and the decline of RRF for automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD). The purpose of our study was to investigate the relative merits or demerits of APD compared with CAPD.From November 1998 to November 2007, we retrospectively reviewed 32 patients on APD and 140 patients on CAPD. We compared incidences of infectious complications during the entry period. RRF and other PD parameters were determined and compared over 2 years of therapy. In addition, the period of hospitalization was also included for clinical outcome analysis.There were no significant differences between the two modalities with regard to the incidence of peritonitis (1.42/100 patient-months for APD vs. 1.23/100 patient-months for CAPD, p = 0.66). At the end of the second year, there were no significant differences between APD and CAPD with regard to the decline of RRF (14.8 vs. 15.3 L/week/1.73 m(2), p = 0.84). However, APD significantly increased the value of total weekly Kt/V during this period. Furthermore, we observed a significant reduction in hospitalized days of APD compared with CAPD.We concluded that the selection of the PD modality is not a major determinant of the decline in RRF. APD can be adapted to the targeted adequacy and is at least as efficacious as CAPD when it is expertly applied.


  • Factors Associated with Blood Concentrations of Indoxyl Sulfate and p-Cresol in Patients Undergoing Peritoneal Dialysis

    by Chien-Te Lee, Chien-Chun Kuo, Yu-Ming Chen, Chung-Yao Hsu, Wen-Chin Lee, Yu-Che Tsai, Hwee-Yeong Ng, Li-Chueh Kuo, Terry Ting-Yu Chiou, Yu-Kun Yang, et al.

    ♦ Background: Accumulating evidence supports the important role of protein-bound uremic toxins such as indoxyl sulfate and p-cresol in uremic syndrome. They exert direct deleterious effects on a variety of cells and could link to clinical outcome. Factors relevant to indoxyl sulfate and p-cresol levels in peritoneal dialysis (PD) patients have rarely been investigated. We conducted a cross-sectional study to analyze the factors that correlate with both total and free indoxyl sulfate and p-cresol.


    • 30 June 2010
      • Vol. 33  (3) , 327-33

    A longitudinal change of peritoneal equilibration test results in peritoneal dialysis patients aged 60 years and above: a 4-year observation study in comparison with a younger group.

    by Miao-Chen Chen, Jin-Bor Chen, Shang-Chih Liao, Kuo-Tai Hsu, King-Kwan Lam, Feng-Rong Chuang, Yu-Shu Chien, Chien-Te Lee, Chih-Shiung Lee, Ben-Chung Cheng

    The number of elderly people with end-stage renal disease has grown in developed countries and medical teams now face the choice of dialysis therapy in elderly patients. In the present study, we retrospectively analyzed two peritoneal dialysis (PD) patients, of different ages, who were treated at the same unit by the same PD team of doctors and nurses. Our purpose was to study peritoneal membrane changes in elderly and younger PD patients. 108 patients above 60 years of age or younger at the start of dialysis, were separated into two cohorts. Diabetic patients were excluded. Peritoneal equilibration test (PET) results taken over 4 continuous years were compared between the two groups. No significant differences were seen between the two groups in peritoneal transport (D/P Cr, D/D0 glucose) during the 4-year observation. Total Kt/V and renal creatinine clearance (Ccr) values in the 4-year period were not significantly different between the two groups. Renal Ccr values showed a longitudinal decline in the two groups but the values of total Kt/V revealed a consistency over the 4-year period. Elderly PD patients demonstrated a similar peritoneal permeability to younger PD patients based on a 4-year PET.

  • Association Between C-Reactive Protein and Biomarkers of Bone and Mineral Metabolism in Chronic Hemodialysis Patients: A Cross-Sectional Study

    by Chien-Te Lee, Yu-Che Tsai, Hwee-Yeong Ng, Yih Su, Wen-Chin Lee, Lung-Chih Lee, Terry Ting-Yu Chiou, Shang-Chih Liao, Kao-Tai Hsu


  • Better Sleep Quality and Less Daytime Symptoms in Patients on Evening Hemodialysis: A Questionnaire‐based Study

    by Chung‐Yao Hsu, Chien‐Te Lee, Yue‐Joe Lee, Tiao‐Lai Huang, Ching‐Yi Yu, Lung‐Chih Lee, King‐Kwan Lam, Yu‐Shu Chien, Feng‐Rong Chuang, Kao‐Tai Hsu

    Abstract:  The aims of this study were to investigate the prevalence of sleep disorders in patients with end‐stage renal disease (ESRD), and to assess the effect of dialysis schedule on sleep quality and the presence of daytime symptoms. We prospectively selected 150 long‐term hemodialysis (HD) patients in three groups (morning, afternoon, and evening dialysis) and gave them a sleep questionnaire, the Epworth sleepiness scale and the Pittsburgh sleep quality index. Snoring was the most common complaint (56%), followed by insomnia (38%) and restless legs syndrome (22.7%). The evening dialysis group experienced more sleep time in bed (P = 0.02), required less hypnotic medication (P = 0.049), had fewer daytime symptoms (P < 0.01), and experienced less daytime sleepiness (P = 0.034). Our study confirms the high prevalence of sleep disorders in ESRD patients, and indicates a beneficial effect of evening HD on sleep quality and reduction of daytime symptoms.